Showing results (581-590 of 651) with videos related to
Sort By:
Pageof 66
Nature Cancer|February 22, 2023
Advances in antibody-based therapy in oncologySacha Zinn, Rodrigo Vazquez-Lombardi, Carsten Zimmermann, et al.Nature Cancer|February 9, 2023
A reversible SRC-relayed COX2 inflammatory program drives resistance to BRAF and EGFR inhibition in BRAFV600E colorectal tumorsAna Ruiz-Saenz, Chloe E Atreya, Changjun Wang, et al.Nature Cancer|March 7, 2025
Hallmarks of artificial intelligence contributions to precision oncologyTian-Gen Chang, Seongyong Park, Alejandro A Schäffer, et al.Nature Cancer|January 21, 2025
Targeting BRCA1-deficient PARP inhibitor-resistant cells with nickases reveals nick resection as a cancer vulnerabilityJenna M Whalen, Jillian Earley, Christi Wisniewski, et al.Nature Cancer|March 18, 2025
Odronextamab monotherapy in patients with relapsed/refractory diffuse large B cell lymphoma: primary efficacy and safety analysis in phase 2 ELM-2 trialWon Seog Kim, Tae Min Kim, Seok-Goo Cho, et al.Nature Cancer|October 22, 2024
Selenocysteine tRNA methylation promotes oxidative stress resistance in melanoma metastasisLeona A Nease, Kellsey P Church, Ines Delclaux, et al.Nature Cancer|October 11, 2024
The neuroendocrine transition in prostate cancer is dynamic and dependent on ASCL1Rodrigo Romero, Tinyi Chu, Tania J González Robles, et al.Nature Cancer|September 3, 2024
A protein expression atlas on tissue samples and cell lines from cancer patients provides insights into tumor heterogeneity and dependenciesJun Li, Wei Liu, Kamalika Mojumdar, et al.Nature Cancer|August 5, 2024
Co-targeting SOS1 enhances the antitumor effects of KRASG12C inhibitors by addressing intrinsic and acquired resistanceVenu Thatikonda, Hengyu Lyu, Sabine Jurado, et al.Nature Cancer|July 15, 2024
p53 at the crossroads of tumor immunityGizem Efe, Anil K Rustgi, Carol PrivesPageof 66